• 1
    American Cancer Society. Cancer facts and figures. Atlanta: American Cancer Society, 1992.
  • 2
    Claus EB, Risch N, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990; 131: 96172.
  • 3
    Harris JR, Lippman ME, Veronesi U, Willett W. Breast cancer (Part 1 of 3). N Engl J Med 1992; 327: 31928.
  • 4
    Ottman R, Pike MC, King MC, Casagrande JT, Henderson BE. Familial breast cancer in a population based series. Am J Epidemiol 1986; 123: 1521.
  • 5
    Sattin RW, Rubin GL, Webster LA, Huezo CM, Wingo PA, Ory HW, et al. and the Cancer and Steroid Hormone Study. Family history and risk of breast cancer. J Am Med Assoc 1985; 253: 190813.
  • 6
    Kelsey JL, Gammon MD. Epidemiology of breast cancer. Epidemiol Rev 1990; 12: 22840.
  • 7
    Kelsey JL, Gammon MD. The epidemiology of breast cancer. CA-A Cancer Journal for Clinicians 1991; 41: 14665.
  • 8
    Lynch HT, Watson P, Conway T, Fitzsimmons SL, Lynch J. Breast cancer family history as a risk factor for early onset breast cancer. Br Cancer Res Treat 1988; 11: 2637.
  • 9
    Anderson DE. Genetic study of breast cancer: identification of a high risk group. Cancer 1974; 34: 10907.
  • 10
    Schwartz AG, King MC, Belle SH, Satariano WA, Swanson GM. Risk of breast cancer to relatives of young breast cancer patients. J Natl Cancer Inst 1985; 75: 6658.
  • 11
    Colditz GA, Willett WC, Hunter DJ, Stampfer MJ, Manson JE, Hennekens CH, et al. Family history, age, and risk of breast cancer: prospective data from the Nurse's Health Study. J Am Med Assoc 1993; 270: 33843.
  • 12
    Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 1991; 48: 23242.
  • 13
    Newman B, Austin MA, Lee M, King MC. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high risk families. Proc Natl Acad Sci USA 1988; 85: 15.
  • 14
    Bishop DT, Cannon-Albright L, McLellan T, Gardner EJ, Skolnick MH. Segregation and linkage analysis of nine Utah breast cancer pedigrees. Genet Epidemiol 1988; 5: 15169.
  • 15
    Williams WR, Anderson DE. Genetic epidemiology of breast cancer: segregation analysis of 200 Danish pedigrees. Genet Epidemiol 1984; 1: 720.
  • 16
    Iselius L, Slack J, Littler M, Morton NE. Genetic epidemiology of breast cancer in Britain. Ann Hum Genet 1991; 55: 1519.
  • 17
    Lynch HT, Conway T, Fitzgibbons RJ Jr., Schreiman J, Watson P, Marcus J, et al. Age at onset heterogeneity in hereditary breast cancer: minimal clues for diagnosis. Br Cancer Res Treat 1988; 12: 27585.
  • 18
    Easton DF, Bishop DT, Ford D, Crockford GP, and the Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993; 52: 678701.
  • 19
    Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 16849.
  • 20
    Hall JM, Friedman L, Guenther Lee, MK, Weber JL, Black DM, et al. Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet 1992; 50: 123542.
  • 21
    Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J, et al. Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 1991; 338: 823.
  • 22
    Young JL, Percy CL, Asire AJ. Surveillance, Epidemiology, and End Results: incidence and mortality data, 1973–1977, National Institutes of Health publication no. 81–2330. Bethesda, MD: Department of Health and Human Services, 1981.
  • 23
    Wingo PA, Ory HW, Layde PM, Lee NC. The evaluation of the data collection process for a multicenter, population-based case-control design. Am J Epidemiol 1988; 128: 20617.
  • 24
    Lalouel JM, Yee S: POINTER: computer programs for complex segregation analysis of nuclear families with pointers. Population Genetics Laboratory Technical Report.
  • 25
    Kaplan EB, Elston RC. A subroutine package for maximum likelihood estimation (MAXLIK). Institute of Statistics Mimeo Services 823. Chapel Hill, NC: University of North Carolina, Chapel Hill, 1972.
  • 26
    Ottman R, Pike MC, King MC, Henderson BE. Practical guide for estimating risk for familial breast cancer. Lancet 1983; 3: 5538.
  • 27
    Anderson DE, Badzioch MD. Risk of familial breast cancer. Cancer 1985; 56: 3837.
  • 28
    Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81: 187986.
  • 29
    Gail MH, Benichou J. Assessing the risk of breast cancer in individuals. In: Devita, VTJr., HellmanS, RosenbergSA, editors. Cancer prevention. Philadelphia: JB Lippincott, 1992: 114.
  • 30
    Morton NE. Diseases determined by major genes. Social Biol 1980; 26: 94103.
  • 31
    Lalouel JM. Recurrence risks in segregation analysis. In: MortonNE, ChungCS, editors. Genetic epidemiology. New York: Academic Press, 1978: 25584.
  • 32
    Bernstein JL, Thompson WD, Risch N, Holford TR. The genetic epidemiology of second primary breast cancer. Am J Epidemiol 1992; 136: 93748.
  • 33
    Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312: 14651.
  • 34
    Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 1988; 128: 46777.
  • 35
    McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D. Histologic types of benign breast disease and the risk of breast cancer: the Cancer and Steroid Hormone Study. Cancer 1992; 69: 140814.
  • 36
    Thompson WD, Schildkraut JM. Family history of gynecologic cancers: relationships to the incidence of breast cancer prior to age 55. Int J Epidemiol 1991; 20: 595602.
  • 37
    Schildkraut JM, Risch N, Thompson WD. Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship. Am J Hum Genet 1989; 45: 5219.
  • 38
    Malkin D, Li FP, Strong LC, Fraumeni JF Jr., Nelson CE, Kim DH, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 12338.
  • 39
    King MC, Rowell S, Love SM. Inherited breast and ovarian cancer. What are the risks? What are the choices? J Am Med Assoc 1993; 269: 197580.
  • 40
    Biesecker BB, Boehnke M, Calzone K, Markel DS, Garber JE, Collins FS, et al. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. J Am Med Assoc 1993; 269: 19704.
  • 41
    Li FP, Garber JE, Friend SH, Strong LC, Patenaude AF, Juengst ET, et al. Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst 1992; 84: 115660.
  • 42
    King MC. Breast cancer genes: how many, where, and who are they? Nature Genet 1992; 2: 8990.
  • 43
    Swift M, Reitnauer PJ, Morrell D, Chase CL. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 1987; 316: 128994.